AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycova-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Gnova Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glycova-M1 Tablet

Diabex Duo tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. These tablets help regulate blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. Diabex Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be recommended by your doctor.

Primary Ingredients of Glycova-M1 Tablet

No text was provided to rewrite.

Uses of Glycova-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glycova-M1 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycova-M1 Tablets should be administered with food.

Common Side effects of Glycova-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycova-M1 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glycova-M1 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with food.

How Glycova-M1 Tablet works:

Glycova-M1 tablets contain a dual-action formulation of glimepiride and metformin, both used in diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glycova-M1 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glycova-M1 Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glycova-M1 Tablets is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycova-M1 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glycova-M1 tablet use. Physician consultation is recommended. Routine kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycova-M1 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is generally advised for those with mild to moderate liver disease; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glycova-M1 Tablet :

Should you forget a Glycova-M1 Tablet dose, take it immediately if remembered. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glycova-M1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycova-M1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glycova-M1 Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glycova-M1 and seek immediate medical attention.
Glycova-M1 tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glycova-M1 is not suitable for type 1 diabetes.
Glycova-M1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Glycova-M1 tablets can induce Vitamin B12 deficiency with prolonged use, hindering its stomach absorption. This can lead to anemia, neurological issues including tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some researchers.
Glycova-M1 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol with Glycova-M1 Tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise your risk of lactic acidosis.
Glycova-M1 Tablet
40
MRP 49
18% off